|
Ryoko Sakai
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules. |
| Journal | Formal name：Annals of the rheumatic diseases Abbreviation：Ann Rheum Dis ISSN code：(1468-2060)0003-4967(Linking) |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 71(11),pp.1820-6 |
| Author and coauthor | Sakai Ryoko, Tanaka Michi, Nanki Toshihiro, Watanabe Kaori, Yamazaki Hayato, Koike Ryuji, Nagasawa Hayato, Amano Koichi, Saito Kazuyoshi, Tanaka Yoshiya, Ito Satoshi, Sumida Takayuki, Ihata Atsushi, Ishigatsubo Yoshiaki, Atsumi Tatsuya, Koike Takao, Nakajima Atsuo, Tamura Naoto, Fujii Takao, Dobashi Hiroaki, Tohma Shigeto, Sugihara Takahiko, Ueki Yukitaka, Hashiramoto Akira, Kawakami Atsushi, Hagino Noboru, Miyasaka Nobuyuki, Harigai Masayoshi, |
| Publication date | 2012/11 |
| Summary | Reasons for discontinuation are significantly different among biological agents. The use of infliximab and tocilizumab was significantly associated with treatment discontinuation due to AE compared with etanercept. |
| DOI | 10.1136/annrheumdis-2011-200838 |
| PMID | 22504558 |